Forest Laboratories Inc. disclosed in its latest annual report on
Form 10-K filed with the U.S. Securities and Exchange Commission
that the company (FLI) and Forest Pharmaceuticals, Inc. (FPI)
remain defendants in several actions regarding overcharging of
Medicaid drug reimbursement…